Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Kameel D. Farag files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Hoyoung Huh - $1.50M of AKTX open-market activity in the last 12 months
- Abizer Gaslightwala - $437K of AKTX open-market activity in the last 12 months
- Raymond Prudo-Chlebosz - $406K of AKTX open-market activity in the last 12 months
- Samir Rashmikant Patel - $344K of AKTX open-market activity in the last 12 months
- Sandip I. Patel - $162K of AKTX open-market activity in the last 12 months
- Robert B. Bazemore - $62K of AKTX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Kameel D. Farag?
Kameel D. Farag is a corporate insider, tracked as Interim CFO of Akari Therapeutics Plc (AKTX). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Kameel D. Farag submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Kameel D. Farag been buying or selling stock?
Recorded transactions: 2 open-market purchases ($10K) and 0 open-market sales across all tracked filings.
Where can I see all of Kameel D. Farag's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Kameel D. Farag and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
